Literature DB >> 19151636

Clinical drug development for childhood cancers.

F M Balis1, E Fox, B C Widemann, P C Adamson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19151636      PMCID： PMC6675566          DOI： 10.1038/clpt.2008.237

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  3 in total

1.  Automated volumetric growth plate measurement using magnetic resonance imaging for monitoring skeletal toxicity in children treated on investigational drug trials.

Authors:  AeRang Kim; Eva Dombi; Jeffrey Solomon; Elizabeth Fox; Frank M Balis; Brigitte C Widemann
Journal:  Clin Cancer Res       Date:  2011-08-01       Impact factor: 12.531

2.  Pediatric phase I trial design using maximum target inhibition as the primary endpoint.

Authors:  Holly Meany; Frank M Balis; Alberta Aikin; Patricia Whitcomb; Robert F Murphy; Seth M Steinberg; Brigitte C Widemann; Elizabeth Fox
Journal:  J Natl Cancer Inst       Date:  2010-05-11       Impact factor: 13.506

3.  Advances in cancer therapeutics.

Authors:  A Sparreboom; J Verweij
Journal:  Clin Pharmacol Ther       Date:  2009-02       Impact factor: 6.875
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.